Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Granules India Ltd Announces Acquisition Of Auctus Pharma And Opening Of New R&D Facility


Monday, 4 Nov 2013 10:07pm EST 

Granules India Ltd announced that the signing of a definitive agreement for the acquisition of Auctus Pharma. The acquisition process is expected to be completed in the next three to six months. Granules also announced that the opening of a 10,000 sq foot R&D facility in Hyderabad. The new R&D facility will focus on full scale generic API development and will supplement the Company's existing R&D facility in Pune which currently focuses on sustainable development. 

Company Quote

630.3
44.5 +7.60%
6:21am EDT